Literature DB >> 24723712

Draft Genome Sequence of Campylobacter ureolyticus Strain CIT007, the First Whole-Genome Sequence of a Clinical Isolate.

Alan Lucid1, Susan Bullman, Monika Koziel, Gerard D Corcoran, Paul D Cotter, Roy D Sleator, Brigid Lucey.   

Abstract

Herein, we present the draft genome sequence of Campylobacter ureolyticus. Strain CIT007 was isolated from a stool sample from an elderly female presenting with diarrheal illness and end-stage chronic renal disease.

Entities:  

Year:  2014        PMID: 24723712      PMCID: PMC3983301          DOI: 10.1128/genomeA.00262-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Campylobacter is the most common cause of gastroenteritis worldwide, with Campylobacter jejuni and Campylobacter coli traditionally believed to be the main species associated with human illness. However, recent studies strongly suggest that Campylobacter ureolyticus may be a significant cause of gastroenteritis, being second only to C. jejuni as the most common cause of campylobacteriosis in southern Ireland (1, 2, 3). In the current study, we isolated Campylobacter ureolyticus strain CIT007 from the stool of an elderly female presenting with diarrheal illness and end-stage chronic renal disease at Cork University Hospital, Cork, Ireland. Campylobacter ureolyticus strain CIT007 was sequenced using a combination of Illumina MiSeq with 250-bp paired-end reads and Roche 454 GS FLX+ single-end reads. Illumina sequencing generated 878,608 reads in pairs with an estimated genome coverage of approximately 200×, while the 454 platform yielded 104,653 reads, giving approximately 30× genome coverage. The reads were assembled de novo by means of a hybrid assembly approach using MIRA (4), resulting in 26 contigs. The total draft genome size is 1,665,887 bp and the estimated G+C content is 29.0 mol%. The genome was annotated using the annotation pipeline Prokka. A total of 1,677 coding sequences (CDS) were identified, with 403 assigned as hypothetical, accounting for 24% of all CDS. Of the total CDS, 116 encoded putative proteins predicted to be secreted using SignalP 4.1 (5). Among the predicted CDS, several putative virulence factors were identified in accordance with our previously published work (6), including genes encoding putative efflux pumps involved in conferring antibiotic resistance (the multidrug and toxic compound extrusion [MATE] family multidrug efflux pump), the archetypal VirB/D4 type IV secretion system (TIVSS), adhesion-associated factors (fibronectin-fibrinogen binding protein), and invasion-associated factors (CiaB). Interestingly, while the TIVSS is most commonly associated with the pVir plasmid of C. jejuni, it appears to be chromosomally integrated in the C. ureolyticus genome. While these virulence factors are likely important drivers of gastrointestinal pathogenicity in humans (and other mammals), further studies are required to investigate the true pathogenic potential of this novel pathogen. Indeed, a current focus of our laboratory is the sequence analysis of multiple C. ureolyticus isolates from a variety of sources, both clinical and environmental, to determine how the pathogen grows and survives both inside and outside the host.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession number JFJK00000000. The version described in this paper is version JFJK01000000.
  5 in total

1.  Emerging dynamics of human campylobacteriosis in Southern Ireland.

Authors:  Susan Bullman; Daniel Corcoran; James O'Leary; Derry O'Hare; Brigid Lucey; Roy D Sleator
Journal:  FEMS Immunol Med Microbiol       Date:  2011-11

2.  SignalP 4.0: discriminating signal peptides from transmembrane regions.

Authors:  Thomas Nordahl Petersen; Søren Brunak; Gunnar von Heijne; Henrik Nielsen
Journal:  Nat Methods       Date:  2011-09-29       Impact factor: 28.547

3.  Molecular-based detection of non-culturable and emerging campylobacteria in patients presenting with gastroenteritis.

Authors:  S Bullman; J O'Leary; D Corcoran; R D Sleator; B Lucey
Journal:  Epidemiol Infect       Date:  2011-05-18       Impact factor: 2.451

4.  Campylobacter ureolyticus: an emerging gastrointestinal pathogen?

Authors:  Susan Bullman; Daniel Corcoran; James O'Leary; Brigid Lucey; Deirdre Byrne; Roy D Sleator
Journal:  FEMS Immunol Med Microbiol       Date:  2010-12-06

5.  Genomic investigation into strain heterogeneity and pathogenic potential of the emerging gastrointestinal pathogen Campylobacter ureolyticus.

Authors:  Susan Bullman; Alan Lucid; Daniel Corcoran; Roy D Sleator; Brigid Lucey
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

  5 in total
  2 in total

Review 1.  Under the microscope: From pathogens to probiotics and back.

Authors:  Roy D Sleator
Journal:  Bioengineered       Date:  2015       Impact factor: 3.269

Review 2.  Pathogenomics of Emerging Campylobacter Species.

Authors:  Daniela Costa; Gregorio Iraola
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.